[HTML][HTML] Hypothermia for moderate or severe neonatal encephalopathy in low-income and middle-income countries (HELIX): a randomised controlled trial in India, Sri …
S Thayyil, S Pant, P Montaldo, D Shukla… - The Lancet Global …, 2021 - thelancet.com
Background Although therapeutic hypothermia reduces death or disability after neonatal
encephalopathy in high-income countries, its safety and efficacy in low-income and middle …
encephalopathy in high-income countries, its safety and efficacy in low-income and middle …
Hypothermia for moderate or severe neonatal encephalopathy in low-income and middle-income countries (HELIX): a randomised controlled trial in India, Sri Lanka …
S Thayyil, S Pant, P Montaldo, D Shukla, V Oliveira… - 2021 - cabidigitallibrary.org
Background: Although therapeutic hypothermia reduces death or disability after neonatal
encephalopathy in high-income countries, its safety and efficacy in low-income and middle …
encephalopathy in high-income countries, its safety and efficacy in low-income and middle …
[HTML][HTML] Hypothermia for moderate or severe neonatal encephalopathy in low-income and middle-income countries (HELIX): a randomised controlled trial in India, Sri …
S Thayyil, S Pant, P Montaldo, D Shukla… - The Lancet Global …, 2021 - thelancet.com
Background Although therapeutic hypothermia reduces death or disability after neonatal
encephalopathy in high-income countries, its safety and efficacy in low-income and middle …
encephalopathy in high-income countries, its safety and efficacy in low-income and middle …
Hypothermia for moderate or severe neonatal encephalopathy in low-income and middle-income countries (HELIX): a randomised controlled trial in India, Sri Lanka …
S Thayyil, S Pant, P Montaldo, D Shukla… - The Lancet. Global …, 2021 - europepmc.org
Background Although therapeutic hypothermia reduces death or disability after neonatal
encephalopathy in high-income countries, its safety and efficacy in low-income and middle …
encephalopathy in high-income countries, its safety and efficacy in low-income and middle …
[引用][C] Hypothermia for moderate or severe neonatal encephalopathy in low-income and middle-income countries (HELIX): a randomised controlled trial in India, Sri …
S Thayyil, S Pant, P Montaldo, D Shukla… - THE LANCET …, 2021 - iris.unicampania.it
Abstract Copyright (c) 2021 The Author (s). Published by Elsevier Ltd. This is an Open
Access article under the CC BY 4.0 license.
Access article under the CC BY 4.0 license.
[HTML][HTML] Hypothermia for moderate or severe neonatal encephalopathy in low-income and middle-income countries (HELIX): a randomised controlled trial in India, Sri …
S Thayyil, S Pant, P Montaldo, D Shukla… - The Lancet Global …, 2021 - Elsevier
Background Although therapeutic hypothermia reduces death or disability after neonatal
encephalopathy in high-income countries, its safety and efficacy in low-income and middle …
encephalopathy in high-income countries, its safety and efficacy in low-income and middle …
[PDF][PDF] Hypothermia for moderate or severe neonatal encephalopathy in low-income and middle-income countries (HELIX): a randomised controlled trial in India, Sri …
S Thayyil, S Pant, P Montaldo, D Shukla, V Oliveira… - 2021 - repository.kln.ac.lk
BACKGROUND: Although therapeutic hypothermia reduces death or disability after
neonatal encephalopathy in high-income countries, its safety and efficacy in low-income and …
neonatal encephalopathy in high-income countries, its safety and efficacy in low-income and …
Hypothermia for moderate or severe neonatal encephalopathy in low-income and middle-income countries (HELIX): a randomised controlled trial in India, Sri Lanka …
S Thayyil, S Pant, P Montaldo, D Shukla, V Oliveira… - 2021 - pubmed.ncbi.nlm.nih.gov
Background Although therapeutic hypothermia reduces death or disability after neonatal
encephalopathy in high-income countries, its safety and efficacy in low-income and middle …
encephalopathy in high-income countries, its safety and efficacy in low-income and middle …
[HTML][HTML] Hypothermia for moderate or severe neonatal encephalopathy in low-income and middle-income countries (HELIX): a randomised controlled trial in India, Sri …
S Thayyil, S Pant, P Montaldo, D Shukla… - The Lancet. Global …, 2021 - ncbi.nlm.nih.gov
Background Although therapeutic hypothermia reduces death or disability after neonatal
encephalopathy in high-income countries, its safety and efficacy in low-income and middle …
encephalopathy in high-income countries, its safety and efficacy in low-income and middle …
Hypothermia for moderate or severe neonatal encephalopathy in low-income and middle-income countries (HELIX): a randomised controlled trial in India, Sri Lanka …
S Thayyil, S Pant, P Montaldo, D Shukla… - The Lancet Global …, 2021 - discovery.ucl.ac.uk
Background: Although therapeutic hypothermia reduces death or disability after neonatal
encephalopathy in high-income countries, its safety and efficacy in low-income and middle …
encephalopathy in high-income countries, its safety and efficacy in low-income and middle …